Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $5.9 million.

  • Metagenomi's Net Cash Flow rose 11642.36% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 10997.13%. This contributed to the annual value of -$113.2 million for FY2024, which is 15349.17% down from last year.
  • Per Metagenomi's latest filing, its Net Cash Flow stood at $5.9 million for Q3 2025, which was up 11642.36% from -$2.3 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Net Cash Flow ranged from a high of $50.2 million in Q3 2023 and a low of -$88.8 million during Q1 2023
  • Its 3-year average for Net Cash Flow is -$13.9 million, with a median of -$2.3 million in 2025.
  • In the last 5 years, Metagenomi's Net Cash Flow crashed by 17177.06% in 2024 and then surged by 11642.36% in 2025.
  • Quarter analysis of 3 years shows Metagenomi's Net Cash Flow stood at $38.7 million in 2023, then plummeted by 94.14% to $2.3 million in 2024, then skyrocketed by 161.04% to $5.9 million in 2025.
  • Its last three reported values are $5.9 million in Q3 2025, -$2.3 million for Q2 2025, and $1.8 million during Q1 2025.